Growth Metrics

Nexalin Technology (NXL) Enterprise Value (2021 - 2025)

Nexalin Technology has reported Enterprise Value over the past 5 years, most recently at -$6.1 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$6.1 million for Q4 2025, down 76.35% from a year ago — trailing twelve months through Dec 2025 was -$6.1 million (down 76.35% YoY), and the annual figure for FY2025 was -$6.1 million, down 76.35%.
  • Enterprise Value for Q4 2025 was -$6.1 million at Nexalin Technology, down from -$4.4 million in the prior quarter.
  • Over the last five years, Enterprise Value for NXL hit a ceiling of -$661778.0 in Q4 2021 and a floor of -$9.0 million in Q3 2024.
  • Median Enterprise Value over the past 5 years was -$4.7 million (2023), compared with a mean of -$4.6 million.
  • Biggest five-year swings in Enterprise Value: crashed 956.84% in 2022 and later skyrocketed 81.93% in 2024.
  • Nexalin Technology's Enterprise Value stood at -$661778.0 in 2021, then crashed by 956.84% to -$7.0 million in 2022, then surged by 32.28% to -$4.7 million in 2023, then increased by 26.53% to -$3.5 million in 2024, then tumbled by 76.35% to -$6.1 million in 2025.
  • The last three reported values for Enterprise Value were -$6.1 million (Q4 2025), -$4.4 million (Q3 2025), and -$5.8 million (Q2 2025) per Business Quant data.